Season's Savings | ₹5/mo for 3 months
₹199/month after first 3 months. Renews automatically. Terms apply.
Decoding 340B: The $81 Billion Drug Discount Program Explained | The Elephant in the Dome
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Decoding 340B: The $81 Billion Drug Discount Program Explained | The Elephant in the Dome
-
Narrated by:
-
Written by:
About this listen
July 30, 2026 MEDIA CONTACT:
Staff Contact Decoding 340B: The $81 Billion Drug Discount Program Explained | The Elephant in the Dome
In this episode of The Elephant in the Dome, Senator Chris Gildon hosts Senator Ron Muzzall the ranking Republican on the Senate Health and Long-Term Care Committee.
They break down the complex 340B Drug Pricing Program—a federal initiative designed to help safety-net health clinics and hospitals acquire discounted prescription medication for low-income patients. They discuss how the program expanded from $12 billion to $81 billion, the balance between supporting struggling community hospitals and keeping private insurance costs manageable, and the legal battle surrounding Senate Bill 5981.
TRANSCRIPT
Washington State Legislature | Official Legislative Email Bulletin
You are receiving this update because you subscribed to email communications from this legislative office. To manage your topic subscriptions or update your subscriber profile, visit GovDelivery.
adbl_web_anon_alc_button_suppression_t1
No reviews yet